AR and prostate cancer: A scRNA-seq-based research found that a subpopulation of CRPC-like cells and a subpopulation of neuroendocrine cells independent of the AR signaling pathway, which share the exact origin as prostate luminal and basal cells, were present in primary prostate cancer tissues without endocrine therapy.